Azitra (AZTR) Net Income towards Common Stockholders (2022 - 2026)

Azitra (AZTR) reported Net Income towards Common Stockholders of -$3.9 million for Q1 2026, down 27.99% on a YoY basis from -$5.5 million in Q1 2025, and down 75.83% quarter-over-quarter from -$2.2 million in Q4 2025.

Azitra (AZTR) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends

Azitra has reported Net Income towards Common Stockholders for 5 years, with the latest figure at -$3.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 27.99% year-over-year to -$3.9 million; the trailing twelve-month figure through Mar 2026 stood at -$11.8 million (down 29.78% YoY), and the FY2025 full-year result was -$11.0 million, down 22.17% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$3.9 million, down from -$2.2 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was -$1.0 million in Q3 2024, with the low at -$5.1 million in Q2 2023.
  • Historically, Net Income towards Common Stockholders has averaged -$2.9 million across 5 years, with a median of -$2.8 million in 2025.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 48.22% — and 2025, when it tumbled 173.85%.
  • Azitra's Net Income towards Common Stockholders stood at -$4.7 million in 2022, then surged by 48.22% to -$2.5 million in 2023, then climbed by 2.47% to -$2.4 million in 2024, then grew by 6.67% to -$2.2 million in 2025, then sank by 75.83% to -$3.9 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$3.9 million (Q1 2026), -$2.2 million (Q4 2025), and -$2.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -13.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 2.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.63 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Azitra 20,900.00 20,900.00 - -3.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.93 Mn
Dec 31, 2025 -2.23 Mn
Sep 30, 2025 -2.76 Mn
Jun 30, 2025 -2.89 Mn
Mar 31, 2025 -3.07 Mn
Dec 31, 2024 -2.39 Mn
Sep 30, 2024 -1.01 Mn
Jun 30, 2024 -2.63 Mn
Mar 31, 2024 -2.93 Mn
Dec 31, 2023 -2.45 Mn
Sep 30, 2023 -1.94 Mn
Jun 30, 2023 -5.07 Mn
Mar 31, 2023 -3.17 Mn
Dec 31, 2022 -4.74 Mn
Sep 30, 2022 -3.11 Mn
Jun 30, 2022 -2.58 Mn